AVE 0.00% 0.3¢ avecho biotechnology limited

marketing of bodyshaper, page-2

  1. 5,863 Posts.
    lightbulb Created with Sketch. 341
    Hi Bumpkin, no I cant tell you what the marketing strategy is. I can only conclude that word of mouth is doing the job and repeat customers. Remember it is the first product that really works. This surely must make a difference when compared to glossy ads and Hollywood actresses smiling in soft lit commercials.

    POH is teetering on being cash flow neutral or maybe even positive for operations now, but still needing to fund Oxy projects and they have money in the bank from the last raising. And also cashed in some money from Prophase.

    Maybe, just maybe, they are conserving cash for the Bio Elixia launch and followup promotions in Asia? Clearly POH are targeting Asia hard. This would make sense for the large market rather than spending the cash on the small market(test?)of Australia.

    I dont know, we may see a huge national campaign next week for all I know.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.32K 440K

Buyers (Bids)

No. Vol. Price($)
30 40522233 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 40065430 31
View Market Depth
Last trade - 14.05pm 15/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.